Cargando…

Review article: an analysis of safety profiles of treatments for diarrhoea‐predominant irritable bowel syndrome

BACKGROUND: Irritable bowel syndrome (IBS) is multifactorial in nature, and a wide range of therapies is available to manage symptoms of this common disorder. AIM: To provide an overview of the safety of interventions that may be used to manage patients with diarrhoea‐predominant IBS (IBS‐D). METHOD...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lacy, Brian E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667996/ https://www.ncbi.nlm.nih.gov/pubmed/30194692 http://dx.doi.org/10.1111/apt.14948

Ejemplares similares

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome
por: Lacy, Brian E
Publicado: (2016)

Acupuncture for Diarrhoea-Predominant Irritable Bowel Syndrome: A Network Meta-Analysis
por: Zhu, Lingping, et al.
Publicado: (2018)

Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
por: Chakraborty, Dwaipayan Sarathi, et al.
Publicado: (2019)

Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity
por: Prospero, Laura, et al.
Publicado: (2021)

Effects of herb-partitioned moxibustion for diarrhoea-predominant irritable bowel syndrome: A protocol for systematic review and meta-analysis
por: Wang, Fen, et al.
Publicado: (2020)

Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
por: Wu, Jing, et al.
Publicado: (2020)

Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome
por: Yang, Jingze, et al.
Publicado: (2021)

Randomized Clinical Trial: The Clinical Effects of Herb-Partitioned Moxibustion in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome
por: Ma, Yu-xia, et al.
Publicado: (2013)

Randomised clinical trial: exploratory phase 2 study of ONO‐2952 in diarrhoea‐predominant irritable bowel syndrome
por: Whitehead, W. E., et al.
Publicado: (2016)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

Irritable Bowel Syndrome: A Review Article
por: Vahedi, H, et al.
Publicado: (2010)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021)

A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea
por: Garsed, Klara, et al.
Publicado: (2014)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Rifaximin is associated with modest, transient decreases in multiple taxa in the gut microbiota of patients with diarrhoea-predominant irritable bowel syndrome
por: Fodor, Anthony A., et al.
Publicado: (2018)

Long-term efficacy and safety of ramosetron in the treatment of diarrhea-predominant irritable bowel syndrome
por: Chiba, Toshimi, et al.
Publicado: (2013)

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers
por: Krogius-Kurikka, Lotta, et al.
Publicado: (2009)

Probiotics in Irritable Bowel Syndrome: A Review Article
por: Sharma, Shatakshi, et al.
Publicado: (2023)

Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial
por: Leighton, Matthew P, et al.
Publicado: (2013)

Constipation-Predominant Irritable Bowel Syndrome Associated to Hyperprolactinemia
por: Seretis, C., et al.
Publicado: (2011)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012)

Comparison of Quality of Life and Psychiatric Symptoms Between Patients With Diarrhea-Predominant Irritable Bowel Syndrome and Those With Constipation-Predominant Irritable Bowel Syndrome
por: BOUSABA, J., et al.
Publicado: (2023)

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2016)

Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review
por: Mangel, Allen W, et al.
Publicado: (2012)

Review article: linaclotide for the management of irritable bowel syndrome with constipation
por: Layer, P, et al.
Publicado: (2014)

Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome
por: Li, Dan-yan, et al.
Publicado: (2017)

Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update
por: Andrews, Christopher N, et al.
Publicado: (2019)

Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients
por: Andrae, David A, et al.
Publicado: (2013)

Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome
por: de los Rios, Constanza Ciriza, et al.
Publicado: (2021)

Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions
por: Cangemi, David J., et al.
Publicado: (2019)

Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
por: Lin, Xianwei, et al.
Publicado: (2019)

Clinical Effects and Safety of Tongxieyaofang on Diarrhea Predominant Irritable Bowel Syndrome: A Meta-Analysis of Randomized Trails
por: Zhou, Yuhong, et al.
Publicado: (2019)

Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
por: Lacy, Brian E., et al.
Publicado: (2017)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Characterization of kynurenine pathway in patients with diarrhea-predominant irritable bowel syndrome
por: Li, Pingping, et al.
Publicado: (2020)

Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation
por: Mourey, Florian, et al.
Publicado: (2022)

Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome
por: Nee, Judy, et al.
Publicado: (2019)

Effects and Mechanisms of Acupuncture on Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review
por: Zhang, Gezhi, et al.
Publicado: (2022)

High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
por: Shiha, Mohamed G., et al.
Publicado: (2020)

Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article
por: Chen, Longtu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n2cn7guhb3ferhp9k75pj1j63j